Tissue Diagnostics Market: Key Insights
The tissue diagnostics market is anticipated to grow at a substantial CAGR during the forecast period, propelled by factors such as the increasing incidence of cancer, technological advancements, and the growing demand for personalized medicine.
One of the major drivers of the tissue diagnostics market is the increasing incidence of cancer. Cancer is the second highest cause of death globally, and cancer cases are expected to increase in the coming years. Tissue diagnostics play a crucial role in the early detection and diagnosis of cancer, which can lead to more effective treatment and improved patient outcomes.
Tissue Diagnostics Market
Tissue Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: by Product (Consumables, and Instruments); Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining); Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Other Diseases); End User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)
Tissue Diagnostics Market Trends and Forecast (2021-2031)
Download Free Sample
Advancements in technology are also driving the expansion of the tissue diagnostics market. The development of new technologies, such as digital pathology, liquid biopsy, and multiplexed assays, helps analyze tissue samples more accurately and efficiently. These advancements are expected to increase the adoption of tissue diagnostics and improve patient outcomes.
The growing demand for personalized medicine also drives the growth of the tissue diagnostics market. Personalized medicine is an approach to healthcare that considers a patient's genetic makeup, lifestyle, and environment. Tissue diagnostics play a crucial role in personalized medicine by providing information about a patient's disease, which can be used to tailor the treatment for the individual. This is expected to increase the demand for tissue diagnostics and improve patient outcomes.
Rise in the Incidences of Cancer Cases to Drive Tissue Diagnostics Market
The growing incidence of cancer cases is a key factor driving the expansion of the tissue diagnostics market. Cancer is a leading cause of death worldwide and the number of cases is projected to continue increasing. Tissue diagnostics plays an essential role in the early detection and diagnosis of cancer, which can lead to more effective treatment and improved patient outcomes. Tissue diagnostics can provide information about the stage of cancer, which can assist in determining the best treatment options and monitoring the disease progression. According to the World Health Organization (WHO), cancer was the first leading cause of death in the people of age below 70 years in 183 countries and the fourth leading cause of death among the population of all ages in 123 countries worldwide in 2019. In addition, as per the data published by the WHO in March 2021, different cancer types caused ~10 million deaths in 2020. The rising number of cancer cases is expected to fuel the demand for tissue diagnostics as early detection and diagnosis is crucial for effective treatment. This is projected to increase the adoption of tissue diagnostics and result in better patient outcomes.
The increasing prevalence of cancer also leads to a rise in demand for various diagnostic methods such as histopathology, molecular diagnostics, and digital pathology. These techniques are crucial for accurate diagnosis and treatment of cancer and are expected to drive the growth of the tissue diagnostics market.
Tissue Diagnostics Market: Segmental Overview
The global tissue diagnostics market is segmented on the basis of product, technology, disease, and end user. Based on product, the global tissue diagnostics market is segmented into consumables and instruments. Consumables segment is further sub-segmented into antibodies, kits, reagents, and probes. Instruments segment is further sub-segmented into slide staining system, scanner, tissue processing system, and other instruments. The global tissue diagnostics market is segmented based on technology into immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management, and special staining. Based on disease, the global tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer (NSCLC), and other diseases. On the basis of end user, the market is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and other end users.
Based on end user, the pharmaceutical companies segment held the substantial share in the market. The pharmaceutical company’s segment is expected to grow significantly in the tissue diagnostics market during the forecast period. Pharmaceutical companies are increasingly investing in tissue diagnostics research and development to develop new drugs and therapies. Tissue diagnostics plays a crucial role in developing new drugs and therapies by providing information about a patient's disease, which can be used to tailor treatment to the individual.
Tissue Diagnostics Market: Competitive Landscape and Key Developments
Thermo Fisher Scientific; Danaher; Becton, Dickinson, and Company; Agilent Technologies; Abbott; Roche; Merck KGa; Biogenex; Hologic Inc.; and Qiagen are among the key players operating in the tissue diagnostics market. These companies have a widespread presence worldwide, which provides lucrative opportunities to serve a large number of customers and expand the market.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com